Skip to Content
MilliporeSigma
All Photos(1)

Documents

40276

Sigma-Aldrich

Hydrofluoric acid

semiconductor grade MOS PURANAL (Honeywell 17928), 49.5-50.5%

Synonym(s):

HF

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
HF
CAS Number:
Molecular Weight:
20.01
EC Number:
MDL number:
UNSPSC Code:
12352106
PubChem Substance ID:

grade

semiconductor grade MOS PURANAL (Honeywell 17928)

vapor density

1.27 (vs air)

vapor pressure

25 mmHg ( 20 °C)

assay

49.5-50.5%

CofA

specification on request

density

1.15 g/mL at 25 °C (lit.)

SMILES string

[H+].[F-]

InChI

1S/FH/h1H

InChI key

KRHYYFGTRYWZRS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

HF is a colorless inorganic acid. Hydrogen fluoride may be formed by reacting calcium fluoride and sulfuric acid at 200oC. The fluoride in the acid has very high affinity to silicon, making it useful in etching or removal of silicon.

Application

Industrial uses of HF include etching or polishing glass, ceramics and silicon surfaces. HF may be used to etch silica capillaries for it behave as a filter and an integrated nanofluidic device for the stacking of DNA and proteins. Dentin and ceramic inlays may be etched with HF for better adhesive bonding. Nanohydroxyapatite was etched with 0.5%HF prior to measuring its morphological and mechanical properties.

Legal Information

PURANAL is a trademark of Honeywell Specialty Chemicals Seelze GmbH

pictograms

Skull and crossbonesCorrosion

signalword

Danger

Hazard Classifications

Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Eye Dam. 1 - Skin Corr. 1A

Storage Class

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Faiez Zannad et al.
European journal of heart failure, 17(7), 735-742 (2015-04-29)
Thrombin is a critical element of crosstalk between pathways contributing to worsening of established heart failure (HF). The aim of this study is to explore the efficacy and safety of rivaroxaban 2.5 mg bid compared with placebo (with standard care) after
Ian Ford et al.
International journal of cardiology, 184, 163-169 (2015-02-24)
We identified easily obtained baseline characteristics associated with outcomes in patients with chronic heart failure (HF) and elevated heart rate (HR) receiving contemporary guideline-recommended therapy in the SHIFT trial, and used them to develop a prognostic model. We selected the
Philip J Millar et al.
Circulation, 131(5), 459-468 (2014-12-04)
Muscle sympathetic activation in heart failure with reduced ejection fraction (HFrEF) has been attributed, on the basis of multiunit recordings, to attenuated inhibitory feedback from stretch-sensitive cardiopulmonary mechanoreceptors. However, such preparations integrate 2 populations of single units exhibiting directionally opposite
Yvonne C J Wientjes et al.
Genetics, selection, evolution : GSE, 47, 42-42 (2015-05-09)
Although simulation studies show that combining multiple breeds in one reference population increases accuracy of genomic prediction, this is not always confirmed in empirical studies. This discrepancy might be due to the assumptions on quantitative trait loci (QTL) properties applied
Barry Greenberg et al.
JACC. Heart failure, 2(1), 84-92 (2014-03-14)
Impaired cardiac isoform of sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA2a) activity is a key abnormality in heart failure patients with reduced ejection fraction. The CUPID 2 (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b) trial is

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service